Your browser doesn't support javascript.
loading
Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis.
Barbour, Sean J; Coppo, Rosanna; Er, Lee; Pillebout, Evangeline; Russo, Maria Luisa; Alpers, Charles E; Fogo, Agnes B; Ferrario, Franco; Jennette, J Charles; Roberts, Ian S D; Cook, H Terence; Ding, Jie; Su, Baige; Zhong, Xuhui; Fervenza, Fernando C; Zand, Ladan; Peruzzi, Licia; Lucchetti, Laura; Katafuchi, Ritsuko; Shima, Yuko; Yoshikawa, Norishige; Ichikawa, Daisuke; Suzuki, Yusuke; Murer, Luisa; Wyatt, Robert J; Park, Catherine; Nelson, Raoul D; Narus, JoAnn H; Wenderfer, Scott; Geetha, Duvuru; Daugas, Eric; Monteiro, Renato C; Nakatani, Shinya; Mastrangelo, Antonio; Nuutinen, Matti; Koskela, Mikael; Weber, Lutz T; Hackl, Agnes; Pohl, Martin; Pecoraro, Carmine; Tsuboi, Nobuo; Yokoo, Takashi; Takafumi, Ito; Fujimoto, Shouichi; Conti, Giovanni; Santoro, Domenico; Materassi, Marco; Zhang, Hong; Shi, Sufang; Liu, Zhi-Hong.
Afiliação
  • Barbour SJ; Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Coppo R; BC Renal, Vancouver, British Columbia, Canada.
  • Er L; Fondazione Ricerca Molinette, Regina Margherita Hospital, Turin, Italy.
  • Pillebout E; BC Renal, Vancouver, British Columbia, Canada.
  • Russo ML; Nephrology Unit, Saint Louis Hospital, Paris, France.
  • Alpers CE; Fondazione Ricerca Molinette, Regina Margherita Hospital, Turin, Italy.
  • Fogo AB; Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington.
  • Ferrario F; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Jennette JC; Department of Medicine and Surgery, IRCCS San Gerardo, University Milan Bicocca, Monza, Italy.
  • Roberts ISD; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
  • Cook HT; Department of Cellular Pathology, Oxford University Hospitals NHS FT, Oxford, United Kingdom.
  • Ding J; Imperial College London, London, United Kingdom.
  • Su B; Department of Pediatrics, Peking University First Hospital, Beijing, China.
  • Zhong X; Department of Pediatrics, Peking University First Hospital, Beijing, China.
  • Fervenza FC; Department of Pediatrics, Peking University First Hospital, Beijing, China.
  • Zand L; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
  • Peruzzi L; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
  • Lucchetti L; Pediatric Nephrology Unit, Regina Margherita Children's Hospital, AOU Città della Salute della Scienza di Torino, Turin, Italy.
  • Katafuchi R; Division of Nephrology, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Shima Y; Kidney Unit, National Hospital Organization Fukuokahigashi Medical Center, Fukuoka, Japan.
  • Yoshikawa N; Department of Pediatrics, Wakayama Medical University, Wakayama, Japan.
  • Ichikawa D; Clinical Research Center, Takatsuki General Hospital, Wakayam Medical University, Takatsuki City, Japan.
  • Suzuki Y; Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
  • Murer L; Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan.
  • Wyatt RJ; Pediatric Nephrology Dialysis and Transplant Unit, Department of Women's and Child's Health, Azienda Ospedaliera-University of Padova, Padua, Italy.
  • Park C; Department of Pediatrics, University of Tennessee Health Sciences Center, Memphis, Tennessee.
  • Nelson RD; Department of Pediatrics, University of Tennessee Health Sciences Center, Memphis, Tennessee.
  • Narus JH; Division of Pediatric Nephrology, Department of Pediatrics, University of Utah, Salt Lake City, Utah.
  • Wenderfer S; Pediatrics Clinical Trials Office, University of Utah, Salt Lake City, Utah.
  • Geetha D; Division of Pediatric Nephrology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Daugas E; Texas Children's Hospital, Houston, Texas.
  • Monteiro RC; Department of Medicine, Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Nakatani S; Nephrology, Bichat Hospital, AP-HP, Paris, France.
  • Mastrangelo A; INSERM U1149 and Université Paris Cité, Paris, France.
  • Nuutinen M; Centre for Research on Inflammation, Bichat Hospital, Inserm and Université Paris Cité, Paris, France.
  • Koskela M; Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Weber LT; Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCC Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
  • Hackl A; Department of Children and Adolescents, Oulu University Hospital, Oulu, Finland.
  • Pohl M; PEDEGO Research Unit, Research Unit for Pediatrics, Dermatology, Clinical Genetics, Obstetrics and Gynecology, Medical Research Center Oulu (MRC Oulu), Oulu, Finland.
  • Pecoraro C; Department of Pediatric Nephrology and Transplantation, New Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Tsuboi N; Pediatric Nephrology, Faculty of Medicine and University Hospital Cologne, Children's and Adolescents' Hospital, University of Cologne, Cologne, Germany.
  • Yokoo T; Pediatric Nephrology, Faculty of Medicine and University Hospital Cologne, Children's and Adolescents' Hospital, University of Cologne, Cologne, Germany.
  • Takafumi I; Medical Center, Department of General Pediatrics, Adolescent Medicine and Neonatology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Fujimoto S; Comitato Tecnico Scientifico per la Ricerca e Innovaziione, A.O. Santobono-Pausilipon, Naples, Italy.
  • Conti G; Division of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Santoro D; Department of Nephrology and Hypertension, Jikei University School of Medicine, Tokyo, Japan.
  • Materassi M; Kidney Center, Department of Internal Medicine, Nephrology, Teikyo University School of Medicine, Teikyo University Chiba Medical Center, Chiba, Japan.
  • Zhang H; Division of Dialysis, Department of Nephrology, University of Miyazaki Hospital, Miyazaki, Japan.
  • Shi S; Pediatric Nephrology and Rheumatology Unit, AOU Policlinic G Martino, University of Messina, Messina, Italy.
  • Liu ZH; Nephrology and Dialysis Unit AOU, G. Martino, University of Messina, Messina, Italy.
Clin J Am Soc Nephrol ; 19(4): 438-451, 2024 Apr 01.
Article em En | MEDLINE | ID: mdl-38261310
ABSTRACT

BACKGROUND:

Nephritis is a common manifestation of IgA vasculitis and is morphologically indistinguishable from IgA nephropathy. While MEST-C scores are predictive of kidney outcomes in IgA nephropathy, their value in IgA vasculitis nephritis has not been investigated in large multiethnic cohorts.

METHODS:

Biopsies from 262 children and 99 adults with IgA vasculitis nephritis ( N =361) from 23 centers in North America, Europe, and Asia were independently scored by three pathologists. MEST-C scores were assessed for correlation with eGFR/proteinuria at biopsy. Because most patients ( N =309, 86%) received immunosuppression, risk factors for outcomes were evaluated in this group using latent class mixed models to identify classes of eGFR trajectories over a median follow-up of 2.7 years (interquartile range, 1.2-5.1). Clinical and histologic parameters associated with each class were determined using logistic regression.

RESULTS:

M, E, T, and C scores were correlated with either eGFR or proteinuria at biopsy. Two classes were identified by latent class mixed model, one with initial improvement in eGFR followed by a late decline (class 1, N =91) and another with stable eGFR (class 2, N =218). Class 1 was associated with a higher risk of an established kidney outcome (time to ≥30% decline in eGFR or kidney failure; hazard ratio, 5.84; 95% confidence interval, 2.37 to 14.4). Among MEST-C scores, only E1 was associated with class 1 by multivariable analysis. Other factors associated with class 1 were age 18 years and younger, male sex, lower eGFR at biopsy, and extrarenal noncutaneous disease. Fibrous crescents without active changes were associated with class 2.

CONCLUSIONS:

Kidney outcome in patients with biopsied IgA vasculitis nephritis treated with immunosuppression was determined by clinical risk factors and endocapillary hypercellularity (E1) and fibrous crescents, which are features that are not part of the International Study of Diseases of Children classification.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vasculite por IgA / Glomerulonefrite por IGA / Nefrite Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vasculite por IgA / Glomerulonefrite por IGA / Nefrite Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article